L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy

Hua Huang1, Ruining Pan1, Yue Zhao2

  • 1Center of Excellence for Environmental Safety and Biological Effects, Beijing International Science and Technology Cooperation Base for Antiviral Drugs, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.

Iscience
|May 6, 2022
PubMed

Insights

L3MBTL2 promotes tumor development by repressing the tumor suppressor CGA. Glycosylated CGA-transcript1 inhibits pancreatic ductal adenocarcinoma (PDAC) by suppressing autophagy.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • L3MBTL2 is a component of ncPRC1.6, involved in transcriptional repression and chromatin compaction.
  • The precise repression mechanisms and biological functions of L3MBTL2 remain largely undefined.
  • Understanding L3MBTL2's role is crucial for elucidating its oncogenic potential.

Purpose of the Study:

  • To investigate the oncogenic role of L3MBTL2 in tumor development.
  • To elucidate the mechanism by which L3MBTL2 represses downstream targets.
  • To determine the tumor suppressor function of CGA and its transcript variants in pancreatic ductal adenocarcinoma (PDAC).

Main Methods:

  • Chromatin immunoprecipitation (ChIP) assays to assess protein-DNA interactions.
  • Quantitative real-time PCR (qRT-PCR) to measure gene expression levels.
  • Western blotting to detect protein levels and post-translational modifications.
  • Cellular assays to evaluate autophagy inhibition and tumor suppressor activity.

Main Results:

  • L3MBTL2 was found to play a distinct oncogenic role in tumor development.
  • L3MBTL2 repressed the downstream gene CGA via an H2AK119ub1-dependent mechanism.
  • The MGA/MAX heterodimer enhanced L3MBTL2's selective repression of CGA.
  • CGA, particularly CGA-transcript1 (T1), exhibited tumor suppressor activity in PDAC.
  • Glycosylated CGA-T1 inhibited PDAC by repressing autophagy through PI3K/Akt/mTOR and TP53INP2 pathways.

Conclusions:

  • L3MBTL2 acts as an oncogene by repressing the tumor suppressor CGA.
  • CGA-T1 possesses tumor suppressor functions in PDAC, mediated by glycosylation and autophagy inhibition.
  • These findings highlight the critical roles of L3MBTL2 and CGA in cancer development and progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K